A detailed history of Harrington Investments, Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Harrington Investments, Inc holds 27,190 shares of NVO stock, worth $3.13 Million. This represents 2.23% of its overall portfolio holdings.

Number of Shares
27,190
Previous 30,618 11.2%
Holding current value
$3.13 Million
Previous $3.93 Million 1.27%
% of portfolio
2.23%
Previous 2.27%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$122.71 - $146.91 $420,649 - $503,607
-3,428 Reduced 11.2%
27,190 $3.88 Million
Q1 2024

Apr 26, 2024

SELL
$102.11 - $135.92 $132,334 - $176,152
-1,296 Reduced 4.06%
30,618 $3.93 Million
Q4 2023

Jan 17, 2024

SELL
$87.78 - $105.45 $233,494 - $280,497
-2,660 Reduced 7.69%
31,914 $3.3 Million
Q3 2023

Oct 19, 2023

BUY
$90.94 - $199.54 $1.55 Million - $3.39 Million
17,001 Added 96.75%
34,574 $3.14 Million
Q2 2023

Jul 20, 2023

SELL
$155.98 - $172.65 $8,578 - $9,495
-55 Reduced 0.31%
17,573 $2.84 Million
Q1 2023

Apr 28, 2023

SELL
$132.34 - $159.14 $14,557 - $17,505
-110 Reduced 0.62%
17,628 $2.81 Million
Q4 2022

Jan 11, 2023

SELL
$102.55 - $135.33 $13,023 - $17,186
-127 Reduced 0.71%
17,738 $0
Q2 2022

Jul 22, 2022

BUY
$103.24 - $121.81 $2,064 - $2,436
20 Added 0.11%
17,865 $1.99 Million
Q1 2022

Apr 26, 2022

SELL
$93.1 - $112.54 $3,537 - $4,276
-38 Reduced 0.21%
17,845 $1.98 Million
Q4 2021

Jan 21, 2022

SELL
$95.88 - $117.08 $27,325 - $33,367
-285 Reduced 1.57%
17,883 $2 Million
Q3 2021

Oct 28, 2021

SELL
$84.42 - $106.62 $8,442 - $10,662
-100 Reduced 0.55%
18,168 $1.74 Million
Q2 2021

Aug 03, 2021

SELL
$67.66 - $84.76 $10,149 - $12,714
-150 Reduced 0.81%
18,268 $1.53 Million
Q1 2021

Apr 30, 2021

SELL
$67.06 - $75.82 $2,481 - $2,805
-37 Reduced 0.2%
18,418 $1.24 Million
Q4 2020

Jan 13, 2021

SELL
$63.89 - $73.8 $69,448 - $80,220
-1,087 Reduced 5.56%
18,455 $1.29 Million
Q3 2020

Oct 21, 2020

SELL
$63.69 - $70.22 $89,166 - $98,308
-1,400 Reduced 6.69%
19,542 $1.36 Million
Q2 2020

Jul 21, 2020

BUY
$58.54 - $67.94 $1,463 - $1,698
25 Added 0.12%
20,942 $1.37 Million
Q1 2020

May 07, 2020

SELL
$49.46 - $64.78 $8,655 - $11,336
-175 Reduced 0.83%
20,917 $1.26 Million
Q4 2019

Feb 10, 2020

SELL
$49.86 - $58.26 $49,760 - $58,143
-998 Reduced 4.52%
21,092 $1.22 Million
Q3 2019

Nov 05, 2019

SELL
$47.54 - $53.43 $5,942 - $6,678
-125 Reduced 0.56%
22,090 $1.14 Million
Q2 2019

Aug 07, 2019

SELL
$46.79 - $52.47 $935 - $1,049
-20 Reduced 0.09%
22,215 $1.13 Million
Q1 2019

Apr 29, 2019

SELL
$46.36 - $52.63 $72,553 - $82,365
-1,565 Reduced 6.58%
22,235 $1.16 Million
Q4 2018

Feb 01, 2019

SELL
$41.54 - $47.25 $14,539 - $16,537
-350 Reduced 1.45%
23,800 $1.1 Million
Q3 2018

Oct 25, 2018

SELL
$46.76 - $51.24 $30,394 - $33,306
-650 Reduced 2.62%
24,150 $1.14 Million
Q2 2018

Oct 19, 2018

SELL
$44.29 - $50.42 $104,081 - $118,487
-2,350 Reduced 8.66%
24,800 $1.14 Million
Q1 2018

Apr 12, 2018

BUY
$48.49 - $58.14 $14,062 - $16,860
290 Added 1.08%
27,150 $1.34 Million
Q4 2017

Feb 01, 2018

SELL
$47.53 - $53.73 $11,169 - $12,626
-235 Reduced 0.87%
26,860 $1.44 Million
Q3 2017

Oct 23, 2017

BUY
$41.15 - $49.22 $1.11 Million - $1.33 Million
27,095
27,095 $1.31 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $260B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Harrington Investments, Inc Portfolio

Follow Harrington Investments, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harrington Investments, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Harrington Investments, Inc with notifications on news.